Rapid tests for tumor, inflammatory and cardiac markers
Rapid biomarker kits for early diagnosis
Cardiovascular diseases, cancer and chronic inflammation are the leading causes of death in Spain. Early detection is vital. Rapid biomarker tests allow markers such as C-reactive protein (CRP), interleukin-6, CEA or CA 15-3 to be identified in less than 10 minutes, helping to anticipate serious complications in primary care. A key tool to improve diagnosis, treatment and patient prognosis.
Thanks to rapid biomarker tests, it is possible to identify risks before serious symptoms appear, improve diagnosis and offer more effective treatment in primary care. These rapid tests allow accurate detection of tumor, inflammatory and cardiac disorders in less than 10 minutes.
Why use rapid biomarker tests?
The key is to detect what you can’t see… and to do it in time.
With a simple sample (whole blood, serum, plasma or stool), you can obtain indicative results in less than 10 minutes:
With a simple sample (whole blood, serum, plasma or stool), you can obtain indicative results in less than 10 minutes:
Differentiate between viral and bacterial infections.
Guidance on the need for antibiotics or specific treatments.
Identify acute or chronic inflammation.
To reduce unnecessary hospitalizations and optimize clinical resources.
Storage
<p>They can be stored at room temperature.</p>
Expiration
<p>Long shelf life available. Up to 2 years. </p>
Results
<p>In 10 minutes you can read the results.</p>
Discover how these kits can transform the way you diagnose. Access our biomarker rapid test catalog now.
What do rapid tests for tumor, inflammatory and cardiac biomarkers detect?
These tests allow immediate identification of alterations that indicate inflammation, cardiac damage or tumor risk, facilitating a more precise clinical approach.
Active inflammation
Ultrasensitive PCR and interleukin-6 for detecting systemic or chronic inflammation
Cardiovascular risk
Detecting early signs associated with heart failure or ischemic heart disease. Troponin I/T for acute events and BNP/NT-proBNP for heart failure,
Presence of tumor processes:
PSA, CEA and AFP as an orientative screening in patients with oncologic risk.
Chronic or silent states:
Rapid and frequent in-office monitoring without hospital referral.
Adapted to multiple environments
Biomarker rapid tests are designed for use in primary care clinics, emergency departments, nursing homes and rural settings. They do not require complex equipment and provide reliable results within minutes, facilitating an agile and effective clinical response where it is most needed.
Need help choosing the right rapid biomarker test?
Complete this form and one of our specialists will contact you to find the best option for your consultation.
Guaranteed quality
All our laboratory equipment and materials for hospitals and laboratories comply with current regulations and the highest quality standards, backed by ISO 9001 certification.
